Tejnaksh Healthcare logo

539428 - Tejnaksh Healthcare Share Price

₹56.4 1.3  2.3%

Last Trade - 15/01/21

Sector
Healthcare
Size
Micro Cap
Market Cap £5.73m
Enterprise Value £6.12m
Revenue £1.28m
Position in Universe 1973rd / 3046
Bullish
Bearish
Unlock 539428 Revenue
Momentum
Relative Strength (%)
1m +9.03%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -5.69%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Mar 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
20.1 47.5 72.8 141.4 197.6 167.6 +52.9%
+4.5 +60.2 +37.9 -56.3 +5.5 -30.9
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 30 September 2020, TejnakshHealthcare Ltd revenues decreased 45% to RS49.3M. Netincome applicable to common stockholders decreased 62% toRS6M. Revenues reflect a decrease in demand for theCompany's products and services due to unfavorable marketconditions. Net income also reflects Other Income decreaseof 94% to RS197K (income), Depreciation and amortizationexpense increase of 9% to RS3.4M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

539428 Revenue Unlock 539428 Revenue

Net Income

539428 Net Income Unlock 539428 Revenue

Normalised EPS

539428 Normalised EPS Unlock 539428 Revenue

PE Ratio Range

539428 PE Ratio Range Unlock 539428 Revenue

Dividend Yield Range

539428 Dividend Yield Range Unlock 539428 Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
539428 EPS Forecasts Unlock 539428 Revenue
Profile Summary

Tejnaksh Healthcare Limited is an India-based company engaged in hospital activities. The Company offers healthcare services at 13 urology clinics, four urology hospitals and two dental super specialty clinics. The Company is operating one hospital at Dhule in Maharashtra. The Company's domains include Urology Hospitals, Nephrology Hospitals, Dental Clinics, Pathology Labs, Research and Development, Healthcare Equipment, Super Specialty Training Institutes, Simulation Institute and Stone Analysis Lab.

Directors
Last Annual March 31st, 2020
Last Interim September 30th, 2020
Incorporated February 18, 2008
Public Since October 27, 2015
No. of Shareholders: n/a
No. of Employees: n/a
Sector Healthcare
Industry Healthcare Providers & Services
Index
Exchange Bombay Stock Exchange
Shares in Issue 10,156,800
Free Float (0.0%)
Eligible for
ISAs
SIPPs
539428 Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for 539428
Upcoming Events for 539428
Frequently Asked Questions for Tejnaksh Healthcare
What is the Tejnaksh Healthcare share price?

As of 15/01/21, shares in Tejnaksh Healthcare are trading at ₹56.4, giving the company a market capitalisation of £5.73m. This share price information is delayed by 15 minutes.

How has the Tejnaksh Healthcare share price performed this year?

Shares in Tejnaksh Healthcare are currently trading at ₹56.4 and the price has moved by 10.48% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Tejnaksh Healthcare price has moved by -6.79% over the past year.

What are the analyst and broker recommendations for Tejnaksh Healthcare?

There are no analysts currently covering Tejnaksh Healthcare.

When will Tejnaksh Healthcare next release its financial results?

Tejnaksh Healthcare is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-09-30
What is the Tejnaksh Healthcare dividend yield?

Tejnaksh Healthcare does not currently pay a dividend.

Does Tejnaksh Healthcare pay a dividend?

Tejnaksh Healthcare does not currently pay a dividend.

When does Tejnaksh Healthcare next pay dividends?

Tejnaksh Healthcare does not currently pay a dividend.

How do I buy Tejnaksh Healthcare shares?

To buy shares in Tejnaksh Healthcare you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Tejnaksh Healthcare?

Shares in Tejnaksh Healthcare are currently trading at ₹56.4, giving the company a market capitalisation of £5.73m.

Where are Tejnaksh Healthcare shares listed? Where are Tejnaksh Healthcare shares listed?

Here are the trading details for Tejnaksh Healthcare:

Country of listing: India
Exchange: BSE
Ticker Symbol: 539428
What kind of share is Tejnaksh Healthcare?

Based on an overall assessment of its quality, value and momentum, Tejnaksh Healthcare is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Tejnaksh Healthcare share price forecast 2021?

We were not able to load any forecast data for Tejnaksh Healthcare.

How can I tell whether the Tejnaksh Healthcare share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Tejnaksh Healthcare. Over the past six months, the relative strength of its shares against the market has been 0.9%. At the current price of ₹56.4, shares in Tejnaksh Healthcare are trading at 41.16% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Tejnaksh Healthcare PE Ratio?

The Tejnaksh Healthcare PE ratio based on its reported earnings over the past 12 months is 49.75. The shares are currently trading at ₹56.4.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Tejnaksh Healthcare?

Tejnaksh Healthcare's management team is headed by:

Ashish Rawandale - MDR
Preeti Rawandale - NED
Kiran Pawar - NID
Vikramsingh Patil - NID
Ramesh Kuwar - CFO
Lokesh Patni - OTH
Gautam Ladumor - OTH
Yaser Ahmedd - OTH
Prakash Sogam - CCO
Sanjay Khatal - NED
Pratap Patil - NED
Who are the major shareholders of Tejnaksh Healthcare?

Here are the top five shareholders of Tejnaksh Healthcare based on the size of their shareholding:

Rawandale (Ashish Vishwas) Individual Investor
Percentage owned: 38.15% (3.87m shares)
Rawandale (Preeti Ashish) Individual Investor
Percentage owned: 35.53% (3.61m shares)
Chavan (Sandeep Achyutrao) Individual Investor
Percentage owned: 2.71% (275k shares)
More (Prashant Janardan) Individual Investor
Percentage owned: 2.23% (226k shares)
Dodamani (Girija) Individual Investor
Percentage owned: 2.04% (207k shares)
Similar to 539428
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.